Keiko Yamagami

Osaka, 5340021, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Anti-pituitary-specific transcription factor-1 hypophysitis developing after thymoma resection: a case report with review of literature.

Anti-pituitary-specific transcription factor-1 hypophysitis developing after thymoma resection: a case report with review of literature.

Journal: Endocrine journal

Published: May 13, 2026

Sonography of thyroid involvement in Langerhans cell histiocytosis.

Sonography of thyroid involvement in Langerhans cell histiocytosis.

Journal: JCEM case reports

Published: February 28, 2026

Peripheral blood UBA1 variant burden predicts poor outcomes in VEXAS syndrome: a nationwide prospective study.

Peripheral blood UBA1 variant burden predicts poor outcomes in VEXAS syndrome: a nationwide prospective study.

Journal: Annals of the rheumatic diseases

Published: October 27, 2025

Novel Thyroid Hormone Receptor β Gene Variant (F245L) Causing Mild Resistance to Thyroid Hormone.

Novel Thyroid Hormone Receptor β Gene Variant (F245L) Causing Mild Resistance to Thyroid Hormone.

Journal: JCEM case reports

Published: August 02, 2025

Severe Agranulocytosis and Thyroid Storm Triggered by Reinitiating Low-Dose Thiamazole: A Cautionary Case.

Severe Agranulocytosis and Thyroid Storm Triggered by Reinitiating Low-Dose Thiamazole: A Cautionary Case.

Journal: JCEM case reports

Published: June 13, 2025

Acute Sheehan Syndrome With Distinctive Arginine Vasopressin Secretion and Magnetic Resonance Imaging Findings.

Acute Sheehan Syndrome With Distinctive Arginine Vasopressin Secretion and Magnetic Resonance Imaging Findings.

Journal: JCEM case reports

Published: March 12, 2025

Long-term safety and efficacy of garadacimab for preventing hereditary angioedema attacks: Phase 3 open-label extension study.

Long-term safety and efficacy of garadacimab for preventing hereditary angioedema attacks: Phase 3 open-label extension study.

Journal: Allergy

Published: July 10, 2024

A Missense Mutation of the Plasminogen Gene in a Japanese Family with Hereditary Angioedema with Normal C1 Inhibitor: Third Family Survey in Asia.

A Missense Mutation of the Plasminogen Gene in a Japanese Family with Hereditary Angioedema with Normal C1 Inhibitor: Third Family Survey in Asia.

Journal: Internal medicine (Tokyo, Japan)

Published: November 23, 2022

Efficacy, pharmacokinetics, and safety of subcutaneous C1-esterase inhibitor as prophylaxis in Japanese patients with hereditary angioedema: Results of a Phase 3 study.

Efficacy, pharmacokinetics, and safety of subcutaneous C1-esterase inhibitor as prophylaxis in Japanese patients with hereditary angioedema: Results of a Phase 3 study.

Journal: Allergology international : official journal of the Japanese Society of Allergology

Published: November 01, 2022

Primary Cutaneous Gamma-Delta T-Cell Lymphoma Initially Diagnosed as Subcutaneous Panniculitis-like T-Cell Lymphoma with Dermatomyositis.

Primary Cutaneous Gamma-Delta T-Cell Lymphoma Initially Diagnosed as Subcutaneous Panniculitis-like T-Cell Lymphoma with Dermatomyositis.

Journal: Dermatopathology (Basel, Switzerland)

Published: March 10, 2022

Impact of diabetes and Krebs von den Lungen-6 on coronavirus disease 2019 severity: A single-center study from Japan.

Impact of diabetes and Krebs von den Lungen-6 on coronavirus disease 2019 severity: A single-center study from Japan.

Journal: Journal of diabetes investigation

Published: December 05, 2021

A case of TAFRO syndrome maintained in remission for 5 years after discontinuation of tocilizumab.

A case of TAFRO syndrome maintained in remission for 5 years after discontinuation of tocilizumab.

Journal: Modern rheumatology case reports

Published: November 11, 2021

Showing 1-12 of 33

Last Updated: 09/26/2026